The Proctor Medal honors excellence in the basic or clinical sciences as applied to ophthalmology. Aguirre was selected for this award at the 2016 ARVO annual meeting, and the award will be presented at the 2017 ARVO meeting where he also will deliver the Proctor Lecture.
Aguirre's research area is the molecular basis of inherited blindness. His team uses dog models to study the genetic mechanisms behind vision impairment. His research spans several vision disorders, including Leber’s congenital amaurosis, Best disease and retinitis pigmentosa.
Aguirre’s approach to developing genetic therapies for dogs with Leber’s congenital amaurosis has paved the way to clinical trials in humans, currently underway.
Penn physicists led by Bo Zhen have created hybrid light-matter particles that interact strongly enough to compute, pointing toward ultrafast, low-energy optical AI hardware.
Penn’s newest supercomputer is transforming research
Penn’s first campus-wide HPC and AI cluster, “Betty,” is expanding access to powerful computing, enabling groundbreaking projects, and fostering new collaborations across disciplines.
A bioengineered bean gum from the lab of Penn Dental’s Henry Daniell is found to reduce the levels of three microbes associated with head and neck squamous cell cancer to almost zero, without affecting the beneficial bacteria normally found in the mouth.
Fighting oral cancer with bioengineered chewing gum
Research led by Penn Dental’s Henry Daniell shows that antiviral and antibacterial chewing gums reduce the levels of three microbes linked to worse outcomes in oral cancers, paving the way for more effective and affordable therapies.
The performing arts at Penn: Process, practice, and purpose
In the vivid tapestry of performing arts groups at Penn, students prepare for their performances while simultaneously enriching their college experience.
